Safety and efficacy of Eltrombopag in the treatment of Immune thrombocytopenia porpura in a routine clinical practice
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2016 New trial record